Delta-Fly Pharma

4598.TTSE GROWTHPharmaceutical
Filed as Delta-Fly Pharma,Inc. (2022-06–2026-06)
Major holders (5%+) · 4
HolderStakeChangeFiled
Evo Fund16.03%-2.31pp2026-11-12
SBI SECURITIES Co., Ltd.8.45%+3.46pp2026-09-25
Kiyoshi Eshima6.18%-1.08pp2026-07-30
Arcus Investment Limited Director/Executive Director Edward Cartwright5.20%—2026-09-08

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 8
Morgan Stanley MUFG Securities Co., Ltd.3.90%2026-06-19
J.P. Morgan Securities LLC2.00%2024-12-18
JPMorgan Securities Japan Co., Ltd.0.54%2024-12-18
J.P. Morgan Securities plc0.46%2024-12-18
Kyoko Eshima0.21%2026-01-26
J.P. Morgan Prime Inc.0.06%2024-12-18
Evolution Capital Management LLC0.00%2026-08-17
Macquarie Bank Limited0.00%2026-08-17
Ownership history · 65
FiledHolderRatioChangePurpose
2026-09-25SBI SECURITIES Co., Ltd.2026-09-258.45%+3.46ppSecurities trading business
2026-09-08Arcus Investment Limited Director/Executive Director Edward Cartwright2026-09-085.20%newHeld for clients (discretionary / trust)
2026-08-17AmendedEvolution Capital Management LLC2026-08-17 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2026-08-17AmendedEvo Fund2026-08-17 · amended22.71%-9.40ppPure investment
2026-08-17AmendedEvolution Capital Management LLC2026-08-17 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2026-08-17AmendedEvo Fund2026-08-17 · amended32.11%-1.28ppPure investment
2026-08-17AmendedEvolution Capital Management LLC2026-08-17 · amended0.00%no changePure investment; Held for clients (discretionary / trust); Asset management / investment
2026-08-17AmendedEvo Fund2026-08-17 · amended33.39%-8.58ppPure investment
2026-08-17AmendedEvolution Capital Management LLC2026-08-17 · amended0.00%newPure investment; Held for clients (discretionary / trust); Asset management / investment
2026-08-17AmendedEvo Fund2026-08-17 · amended41.97%newPure investment
2026-07-30AmendedKiyoshi Eshima2026-07-30 · amended6.18%-1.08ppStable shareholder
2026-06-19AmendedMorgan Stanley MUFG Securities Co., Ltd.2026-06-19 · amended3.90%newSecurities trading business
2026-01-26Kyoko Eshima2026-01-260.21%-0.05ppStable shareholder
2026-01-26Kiyoshi Eshima2026-01-267.26%-1.80ppStable shareholder
2026-01-08SBI SECURITIES Co., Ltd.2026-01-084.99%-0.05ppSecurities trading business
2025-12-19SBI SECURITIES Co., Ltd.2025-12-195.04%+0.31ppSecurities trading business
2025-12-04SBI SECURITIES Co., Ltd.2025-12-044.73%-1.54ppSecurities trading business
2025-11-07SBI SECURITIES Co., Ltd.2025-11-076.27%+0.35ppSecurities trading business
2025-10-21SBI SECURITIES Co., Ltd.2025-10-215.92%+0.68ppSecurities trading business
2025-10-07SBI SECURITIES Co., Ltd.2025-10-075.24%+0.78ppSecurities trading business

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.